Aldeyra Therapeutics, Inc.
Pharmaceutical company · Lexington, Massachusetts, United States · Nasdaq: ALDX
Aldeyra Therapeutics, Inc. is a pharmaceutical company headquartered in Lexington, Massachusetts, United States. Its shares trade on Nasdaq under the ticker ALDX. It has reported private securities offerings to the US SEC, most recently $10 million sold in a notice filed in 2019.
Aldeyra Therapeutics at a glance
What does Aldeyra Therapeutics do?
Private fundraising reported to the SEC
4 Form D notices; the most recent reported $10 million sold (2019).
Frequently asked questions about Aldeyra Therapeutics
Where is Aldeyra Therapeutics headquartered?
Aldeyra Therapeutics, Inc. is headquartered in Lexington, Massachusetts, United States.
What does Aldeyra Therapeutics do?
Aldeyra Therapeutics, Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
Is Aldeyra Therapeutics a public company?
Yes. Aldeyra Therapeutics, Inc. trades on Nasdaq under the ticker ALDX.
Similar companies
- Dicerna Pharmaceuticals IncLexington, Massachusetts, United States
- Keros Therapeutics, Inc.Lexington, Massachusetts, United States
- Acusphere IncLexington, Massachusetts, United States
- Triana Biomedicines, Inc.Lexington, Massachusetts, United States
- Concert Pharmaceuticals, Inc.Lexington, Massachusetts, United States
- Murty Pharmaceuticals, Inc.Lexington, Kentucky, United States
- Summit Biosciences Inc.Lexington, Kentucky, United States
- Avana Health, Inc.Lexington, Kentucky, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-24. Data licences